Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients - Chen, Chao (China International Cooperation Center for Environment and Human Health. Nanjing Medical University) ; Wei, Yongyue (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Wei, Liangmin (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Chen, Jiajin (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Chen, Xin (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Dong, Xuesi (Department of Epidemiology and Biostatistics. School of Public Health. Southeast University) ; He, Jieyu (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Lin, Lijuan (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Zhu, Ying (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Huang, Hui (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; You, Dongfang (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Lai, Linjing (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Shen, Sipeng (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Duan, Weiwei (Department of Bioinformatics. School of Biomedical Engineering and Informatics. Nanjing Medical University) ; Su, Li (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Shafer, Andrea (Harvard Medical School) ; Fleischer, Thomas (Department of Cancer Genetics. Institute for Cancer Research. Oslo University Hospital) ; Bjaanæs, Maria Moksnes (Department of Cancer Genetics. Institute for Cancer Research. Oslo University Hospital) ; Karlsson, Anna (Division of Oncology and Pathology. Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research. Lund University) ; Planck, Maria (Division of Oncology and Pathology. Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research. Lund University) ; Wang, Rui (Department of Medical Oncology. Jinling Hospital. School of Medicine. Nanjing University) ; Staaf, Johan (Division of Oncology and Pathology. Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research. Lund University) ; Helland, Åslaug (Institute of Clinical Medicine. University of Oslo) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zhang, Ruyang (Department of Medical Oncology. Jinling Hospital. School of Medicine. Nanjing University) ; Chen, Feng (Jiangsu Key Lab of Cancer Biomarkers. Prevention and Treatment. Cancer Center. Collaborative Innovation Center for Cancer Personalized Medicine. Nanjing Medical University) ; Christiani, David C (Harvard Medical School) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.